News Daily News Los Beneficios del Ejercicio Físico No se Ven Afectados por la Historia Familiar de Cardiopatía Yael L. Maxwell September 08, 2016
News Daily News Las Tendencias en el Desarrollo de Fármacos Cardiovasculares Indican Problemas y Posibilidades Durante la Fase de Desarrollo Caitlin E. Cox September 08, 2016
News Daily News Patient-Level Data Supports PCI for Some Patients with Unprotected Left Main Disease Yael L. Maxwell September 07, 2016
News Daily News FDA Expands Indications for Two Endovascular Stroke Therapies Todd Neale September 06, 2016
News Conference News ESC 2016 Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy Todd Neale September 02, 2016
News Conference News ESC 2016 Simplified VTE Protocol Rules Out Pulmonary Embolism, Reduces Use of CT Imaging: YEARS Study Michael O'Riordan September 02, 2016
News Daily News Short-term DAPT Not Necessarily the Best Option for All, Especially After Complex PCI Yael L. Maxwell September 02, 2016
News Daily News FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy Yael L. Maxwell September 02, 2016
News Daily News El Tratamianto Antiplaquetario Doble a Corto Plazo No es la Mejor Opción para Todos, Especialmente Tras una PCI Compleja Yael L. Maxwell September 02, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2016 Caitlin E. Cox September 01, 2016
News Industry News St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation September 01, 2016
News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016
News Conference News ESC 2016 Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4 Todd Neale August 31, 2016
News Industry News InCarda Therapeutics Initiates Enrollment of Phase 1 Clinical Trial of Inhaled Flecainide for the Treatment of Cardiac Arrhythmias August 31, 2016
News Industry News Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy August 31, 2016
News Conference News ESC 2016 Day or Night, STEMI Patients Receive Similar Levels of Quality Care L.A. McKeown August 31, 2016
News Conference News ESC 2016 BASKET-SAVAGE: DES Reign for Saphenous Vein Graft PCI Amid Declining Use Shelley Wood August 31, 2016